PRIME THERAPEUTICS for PRIME THERAPEUTICS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.2214 The DRUG Act - provisions related to PBM compensation. H.R.10445 (118th Congress), Further Consolidating Appropriations and Disaster Relief Supplemental Appropriations Act, Division E, Healthcare, provisions regulating pharmacy benefit managers. H.R.5378 (118th Congress), Lower Cost, More Transparency Act. Advanced Premium Tax Credits continuation. S.526 Pharmacy Benefit Manger Transparency Act of 2025. S.891, The Bipartisan Health Care Act, provisions related to PBM regulation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE CAROL CANTOR-WEINBERG | — |
Medicare/Medicaid MMM
S.891, The Bipartisan Health Care Act, provisions related to PBM regulation. H.R.10445 (118th Congress), Further Consolidating Appropriations and Disaster Relief Supplemental Appropriations Act, Division E, Healthcare, provisions regulating pharmacy benefit managers. H.R.5378 (118th Congress), Lower Cost, More Transparency Act. Advanced Premium Tax Credits continuation. S.526 Pharmacy Benefit Manger Transparency Act of 2025. Medicare and Medicaid Programs: Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly; RIN 0938-AV40, provisions related to coverage of anti-obesity medications in Medicare Part D and Medicaid.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE CAROL CANTOR-WEINBERG | — |
Trade (domestic/foreign) TRD
Tariffs on pharmaceuticals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE CAROL CANTOR-WEINBERG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.